Yokogawa Electric Corporation announces the release today of OpreX™ Quality Management System, a product in the OpreX Operational Risk Management family.
Delix plans further trials with neuroplastogen after positive Phase I data – Pharmaceutical Technology
DLX-001 is a neuroplastogen designed to promote neuroplasticity without giving rise to the deleterious attributes of first- and second-generation psychedelics. Credits: 15Studio/Shutterstock.com Delix Therapeutics is